Carl Zeiss Meditec AG buy exploration
Summary
This prediction ended on 08.12.14 with a price of €20.59. With a performance of -5.88%, the BUY prediction by exploration finished with a loss. exploration has 50% into this predictionCarl Zeiss Meditec AG is a German-based company that produces medical devices for ophthalmology and microsurgery. It operates in two segments: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment includes diagnostic and surgical equipment for the anterior and posterior segments of the eye. The Microsurgery segment offers products for neurosurgery, spinal and ENT surgeries, and dental applications. The company has a global reach and serves customers in more than 115 countries through its subsidiaries and distribution network. Carl Zeiss Meditec has been listed on the Frankfurt and TecDAX stock exchanges since 2007.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Carl Zeiss Meditec AG | -0.596% | -0.596% | -17.170% | -30.631% |
| iShares Core DAX® | 0.476% | -0.039% | 13.342% | 17.330% |
| iShares Nasdaq 100 | 1.290% | 0.504% | 40.099% | 50.534% |
| iShares Nikkei 225® | 1.300% | -2.135% | 19.861% | 4.937% |
| iShares S&P 500 | 0.829% | 0.193% | 29.756% | 43.432% |
Comments by exploration for this prediction
In the thread Carl Zeiss Meditec AG diskutieren
schwacher Start 2014, aber bessere Aussichten
Die Aktie ist schwach ins 1. Quartal 2014 gestartet. Die Meinungen einiger Analysten für die Zukunft ist dagegen positiv. Somit kann der Kursrückgang als Chance für einen Einstieg genutzt werden.
Am 04.03.2014 ist die Hauptversammlung.